Ladenburg Thalmann Financial Services’s Minerva Neurosciences NERV Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$14K	Buy	+250	New	+$11K	﹤0.01%	4327

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

IVAI

Index Venture Associates IV St. Helier, Channel Islands, Jersey $6.24M AUM

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Ladenburg Thalmann Financial Services's NERV Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services opened a new position in Minerva Neurosciences (NERV) in Q4 2019: 250 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #4327 among its holdings.

92 funds tracked by Wall St. Rank hold NERV as of Q4 2019.

Ladenburg Thalmann Financial Services held 250 shares of Minerva Neurosciences worth $14K as of Q4 2019.
Minerva Neurosciences was a new Ladenburg Thalmann Financial Services position in Q4 2019.
Minerva Neurosciences made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4327 holding.
92 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.